Michelle G. Burris's most recent trade in Adaptive Biotechnologies Corp was a trade of 52,084 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 25, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Adaptive biotech Corp | Michelle G. Burris | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jun 2026 | 52,084 | 0 | - | - | Stock Option (right to buy) | |
| Adaptive biotech Corp | Michelle G. Burris | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.80 per share. | 25 Jun 2026 | 52,084 | 67,709 (0%) | 0% | 7.8 | 406,255 | Common Stock |
| Adaptive biotech Corp | Michelle G. Burris | Director | Sale of securities on an exchange or to another person at price $ 20.18 per share. | 25 Jun 2026 | 52,084 | 15,625 (0%) | 0% | 20.2 | 1,051,055 | Common Stock |
| Adaptive biotech Corp | Michelle G. Burris | Director | Sale of securities on an exchange or to another person at price $ 13.91 per share. | 11 Mar 2026 | 15,394 | 15,625 (0%) | 0% | 13.9 | 214,131 | Common Stock |
| Adaptive biotech Corp | Michelle G. Burris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2026 | 15,625 | 31,019 (0%) | 0% | 0 | Common Stock | |
| Adaptive biotech Corp | Michelle G. Burris | Director | Sale of securities on an exchange or to another person at price $ 7.19 per share. | 13 Mar 2025 | 36,291 | 15,394 (0%) | 0% | 7.2 | 260,932 | Common Stock |
| Adaptive biotech Corp | Michelle G. Burris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 23,726 | 23,726 | - | - | Stock Option (right to buy) | |
| Adaptive biotech Corp | Michelle G. Burris | Director | Sale of securities on an exchange or to another person at price $ 7.94 per share. | 04 Mar 2025 | 15,664 | 51,685 (0%) | 0% | 7.9 | 124,372 | Common Stock |
| Adaptive biotech Corp | Michelle G. Burris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 15,394 | 67,349 (0%) | 0% | 0 | Common Stock | |
| Adaptive biotech Corp | Michelle G. Burris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 48,044 | 48,044 | - | - | Stock Option (right to buy) | |
| Adaptive biotech Corp | Michelle G. Burris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 31,328 | 51,955 (0%) | 0% | 0 | Common Stock | |
| Acer Therapeutics Inc | Michelle G. Burris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2023 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Acer Therapeutics Inc | Michelle G. Burris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 18,500 | 18,500 | - | - | Stock Option (right to buy) |